BioMarin Pharmaceutical Inc. (OQ:BMRN)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -8,000 $87.95
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $21.51
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $84.92
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $21.51
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -3,000  
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -3,000 $84.46
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,000 $21.51
Dec 30/19 Dec 27/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BMRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -8,000 $87.95
Jan 16/20 Jan 14/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $21.51
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -4,000  
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -3,000  
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -4,000 $84.92
Jan 9/20 Jan 8/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,000 $21.51
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Common Stock S - Open market or private sale -3,000 $84.46
Jan 9/20 Jan 7/20 Bienaime Jean Jacques Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,000 $21.51
Dec 30/19 Dec 27/19 Bienaime Jean Jacques Direct Ownership Stock Option (Right to buy Common Stock) M - Exercise or conversion exempt under rule 16b-3 -5,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BMRN

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Aptinyx (OQ:APTX)
Twist Bioscience (OQ:TWST)